SCHEMBL907747

SCHEMBL907747

COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCC1CC2CN(C)CC2C1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHA2 P29317 20/20 1.00
KDR P35968 20/20 1.00
EPHB4 P54760 17/20 1.00
ERBB2 P04626 12/20 1.00
FLT1 P17948 10/20 1.00
GAK O14976 1/20 0.85
EPHB6 O15197 1/20 0.85
RIPK2 O43353 1/20 0.85
STK10 O94804 1/20 0.85
MAP4K4 O95819 1/20 0.85
ABL1 P00519 1/20 0.85
EGFR P00533 1/20 0.85
LCK P06239 1/20 0.85
YES1 P07947 1/20 0.85
LYN P07948 1/20 0.85
RET P07949 1/20 0.85
HCK P08631 1/20 0.85
BCR P11274 1/20 0.85
SRC P12931 1/20 0.85
EPHA1 P21709 1/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3627785 1.00 EPHA2 (1.00) EPHA2KDREPHB4ERBB2FLT1
SCHEMBL907745 1.00 EPHA2 (1.00) EPHA2KDREPHB4ERBB2FLT1
SCHEMBL907749 1.00 EPHA2 (1.00) EPHA2KDREPHB4ERBB2FLT1
SCHEMBL3029738 1.00 EPHA2 (1.00) EPHA2KDREPHB4ERBB2FLT1
Hydrochloric Acid SCHEMBL906932 0.99 EPHA2 (0.98) EPHA2KDREPHB4ERBB2FLT1
Hydrochloric Acid SCHEMBL906933 0.99 EPHA2 (0.98) EPHA2KDREPHB4ERBB2FLT1
Hydrochloric Acid SCHEMBL906931 0.99 EPHA2 (0.98) EPHA2KDREPHB4ERBB2FLT1
SCHEMBL4564828 0.93 EPHA2 (0.90) EPHA2KDREPHB4ERBB2FLT1
SCHEMBL1790263 0.93 KDR (1.00) EPHA2KDREPHB4ERBB2FLT1
SCHEMBL4383978 0.93 KDR (1.00) EPHA2KDREPHB4ERBB2FLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2139484-B1 METHODS OF TREATING CANCER USING PYRIDOPYRIMIDINONE INHIBITORS OF PI3K ALPHA EXELIXIS INC (US) 2013-07-17 EP disclosed
EP-2277867-A2 Compounds, pharmaceutical compositions thereof and their use in treating cancer Symphony Evolution, Inc. (US) 2011-01-26 EP disclosed